Last reviewed · How we verify
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Details
| Lead sponsor | Children's Oncology Group |
|---|---|
| Phase | PHASE2 |
| Status | RECRUITING |
| Enrolment | 240 |
| Start date | Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Nov 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Basal Ganglia Germinoma
- Diabetes Insipidus
- Germinoma
- Pineal Region Germinoma
- Suprasellar Germinoma
- Thalamic Germinoma
Interventions
- 3-Dimensional Conformal Radiation Therapy
- Biospecimen Collection
- Carboplatin
- Etoposide
- Intensity-Modulated Radiation Therapy
- Lumbar Puncture
- Magnetic Resonance Imaging
- Questionnaire Administration
- Surgical Procedure
Countries
Canada, United States, Australia